Literature DB >> 8117307

Cloning of a complete protein-coding sequence of human platelet-type phosphofructokinase isozyme from pancreatic islet.

K Eto1, H Sakura, K Yasuda, T Hayakawa, E Kawasaki, R Moriuchi, S Nagataki, Y Yazaki, T Kadowaki.   

Abstract

We have cloned a full length protein-coding sequence of human platelet-type phosphofructokinase (PFK) from pancreatic islet cDNA library. The platelet-type PFK was composed of 784 amino acids and had a deduced molecular weight of 85,590. Homologies in the primary structure with muscle- and liver-type PFK were 71 and 67%. Clear similarities of the amino and carboxyl halves with a prokaryotic PFK indicated an evolutionary event that duplicated genes of a prototype PFK fused into larger genes of eukaryotic PFKs. Amino acid residues constituting the binding sites for various allosteric modulators were well conserved, while a couple of different residues at the inhibitory ATP sites among three isozymes may partly explain their varied degree of sensitivities to ATP. Considerable amount of platelet-type PFK expression was demonstrated in brain, heart, kidney, colon and testis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8117307     DOI: 10.1006/bbrc.1994.1141

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Expression of mouse phosphofructokinase-M gene alternative transcripts: evidence for the conserved two-promoter system.

Authors:  H Nakajima; T Noguchi; T Hamaguchi; K Tomita; T Hanafusa; N Kono; T Tanaka; M Kuwajima; Y Matsuzawa
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

2.  Posttranslational modification of 6-phosphofructo-1-kinase as an important feature of cancer metabolism.

Authors:  Andreja Šmerc; Eva Sodja; Matic Legiša
Journal:  PLoS One       Date:  2011-05-04       Impact factor: 3.240

3.  Multi-tissue computational modeling analyzes pathophysiology of type 2 diabetes in MKR mice.

Authors:  Amit Kumar; Thomas Harrelson; Nathan E Lewis; Emily J Gallagher; Derek LeRoith; Joseph Shiloach; Michael J Betenbaugh
Journal:  PLoS One       Date:  2014-07-16       Impact factor: 3.240

4.  The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing.

Authors:  Valentina Tesori; Anna Chiara Piscaglia; Daniela Samengo; Marta Barba; Camilla Bernardini; Roberto Scatena; Alessandro Pontoglio; Laura Castellini; Johannes N Spelbrink; Giuseppe Maulucci; Maria Ausiliatrice Puglisi; Giovambattista Pani; Antonio Gasbarrini
Journal:  Sci Rep       Date:  2015-03-17       Impact factor: 4.379

5.  Uterine glycolytic enzyme expression is affected by knockout of different estrogen receptor subtypes.

Authors:  Min Hu; Yuehui Zhang; Emil Egecioglu; Xin Li; Linus R Shao; Håkan Billig
Journal:  Biomed Rep       Date:  2019-08-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.